Selbyville, Delaware , July 27, 2021 (GLOBE NEWSWIRE) -- According to credible sources, global vaccine adjuvants market size was valued at USD 0.70 billion in 2020 and is estimated to record a CAGR of 10.5% over 2021-2027, subsequently accumulating a valuation of USD 1.4 billion by the end of forecast period. Increased prevalence of infectious as well as zoonotic diseases, and rising focus of government bodies of various nation on immunization programs are the major factors responsible for this growth.
The study also emphasizes on the market segmentations, including product type, disease type, and application ambit along with regional landscape, thereby disclosing the remunerative prospects for investment in the following years.
Moreover, it elucidates the company profiles of prominent players to get a clear picture of the competitive scenario and draft beneficial strategies. Lastly, the impact of COVID-19 pandemic is analyzed to comprehend the market uncertainties during and after this global crisis.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3991262/
For instance, many governmental organizations worldwide are creating awareness and promoting vaccination against diseases like anthrax, hepatitis, BCG, varicella, HPV, smallpox, influenza, and other illnesses. In 2019, the government in the U.S. allocated USD 290 million in foreign aid to the Global Alliance for Vaccines and Immunization (GAVI) and USD 226 million to the U.S. Department of Health and Human Services (HHS) to assist child vaccine campaigns in other countries.
For the record, vaccine adjuvant is an immunological ingredient that alters the effects of other agents. It is used in some vaccines to boost the immune response and help the vaccines to work better by offering a long-lasting protection against the antigen. The most widely used adjuvants are paraffin oil and aluminum hydroxide.
On the downside, strict regulatory framework with time-consuming approvals, in consort with expensive adjuvant research are likely to restrain the market progression over the analysis period.
Market segmentation overview
Based on product type, worldwide vaccine adjuvants industry is segmented into pathogen components, particulate adjuvants, adjuvant emulsions, and combination adjuvants including others. On the basis of route of administration, the marketplace is divided into oral, intranasal, subcutaneous, intradermal, and intramuscular among others.
Speaking of the application range, the business space is categorized into research applications, and commercial applications. Considering the disease type, the industry space is fragmented into infectious diseases, and cancer among others.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Geographical outlook
As per expert analysts, North America is likely to serve as a lucrative growth avenue for global vaccine adjuvants market through 2027, owing to the rise in life-threatening epidemic illnesses, coupled with growing investments for research & development of innovative medicines. Moreover, presence of prominent market players in the U.S. is increasing the product penetration, thereby contributing to the market growth.
Global Vaccine Adjuvants Market, by Product Type (Revenue, USD Billion, 2018-2027)
- Pathogen Components
- Adjuvant Emulsions
- Particulate Adjuvants
- Combination Adjuvants
- Others
Global Vaccine Adjuvants Market, by Route of Administration (Revenue, USD Billion, 2018-2027)
- Oral
- Subcutaneous
- Intranasal
- Intramuscular
- Intradermal
- Others
Global Vaccine Adjuvants Market, by Application (Revenue, USD Billion, 2018-2027)
- Research Applications
- Commercial Applications
Global Vaccine Adjuvants Market, by Disease Type (Revenue, USD Billion, 2018-2027)
- Infectious Diseases
- Cancer
- Others
Global Vaccine Adjuvants Market Regional Terrain (Revenue, USD Billion, 2018-2027)
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Mexico
- Brazil
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Rest of the World
Global Vaccine Adjuvants Market Competitive Dashboard (Revenue, USD Billion, 2018-2027)
- OZ Biosciences
- MVP Laboratories, Inc.
- Avanti Polar Lipids, Inc.
- SPI Pharma, Inc.
- InvivoGen
- Novavax, Inc.
- Agenus, Inc.
- CSL Limited
- Seppic S.A.
- Brenntag Biosector A/S
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Vaccine Adjuvants Market, by Region, 2019-2027 (USD Billion)
1.2.2. Vaccine Adjuvants Market, by Product type, 2019-2027 (USD Billion)
1.2.3. Vaccine Adjuvants Market, by Route of administration, 2019-2027 (USD Billion)
1.2.4. Vaccine Adjuvants Market, by Application, 2019-2027 (USD Billion)
1.2.5. Vaccine Adjuvants Market, By Disease type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Vaccine Adjuvants Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Vaccine Adjuvants Market Dynamics
3.1. Vaccine Adjuvants Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High prevalence of infectious and zoonotic diseases
3.1.1.2. Increasing focus on immunization programs from various government bodies
3.1.2. Market Restraint
3.1.2.1. Stringent regulatory environment and time-consuming approvals
3.1.2.2. High cost of adjuvant research
3.1.3. Market Opportunities
3.1.3.1. Pandemic diseases
3.1.3.2. Combination adjuvants
Chapter 4. Global Vaccine Adjuvants Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Vaccine Adjuvants Market, by Product type
5.1. Market Snapshot
5.2. Global Vaccine Adjuvants Market by Product type, Performance - Potential Analysis
5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Product type 2018-2027 (USD Billion)
5.4. Vaccine Adjuvants Market, Sub Segment Analysis
5.4.1. Pathogen Components
5.4.2. Adjuvant Emulsions
5.4.3. Particulate Adjuvants
5.4.4. Combination Adjuvants
5.4.5. Others
Chapter 6. Global Vaccine Adjuvants Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Vaccine Adjuvants Market by Route of Administration, Performance - Potential Analysis
6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Route of administration 2018-2027 (USD Billion)
6.4. Vaccine Adjuvants Market , Sub Segment Analysis
6.4.1. Oral
6.4.2. Subcutaneous
6.4.3. Intranasal
6.4.4. Intramuscular
6.4.5. Intradermal
6.4.6. Others
Chapter 7. Global Vaccine Adjuvants Market, by Disease type
7.1. Market Snapshot
7.2. Global Vaccine Adjuvants Market by Disease type, Performance - Potential Analysis
7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Disease type 2018-2027 (USD Billion)
7.4. Vaccine Adjuvants Market, Sub Segment Analysis
7.4.1. Research Applications
7.4.2. Commercial Applications
Chapter 8. Global Vaccine Adjuvants Market, by Application
8.1. Market Snapshot
8.2. Global Vaccine Adjuvants Market by Application, Performance - Potential Analysis
8.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
8.4. Vaccine Adjuvants Market , Sub Segment Analysis
8.4.1. Research and Development
8.4.2. Clinical Diagnostics
Chapter 9. Global Vaccine Adjuvants Market, Regional Analysis
Related Report:
Global mRNA Vaccine and Therapeutics Market - Analysis By Product, End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of Covid-19 (2021-2030)
The Global mRNA Vaccine and Therapeutic Market size is estimated at USD 29672.31 Million in the year 2025. The growing occurrences of chronic and infectious diseases, such as diabetes, HIV, cancer and CVDs, is one of the major key factors driving the growth of the market. The growing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections as well as inability of traditional vaccine approach to find vaccines at the critical time are also providing a boost to the market growth. Compared to conventional medicines, mRNA vaccines and Therapeutics are developed with the help of advanced technologies which are more effective against pathogens, have higher effectiveness, improved immunogenicity and require less cost to produce. Moreover, developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market growth. The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are actively engaged in developing next generation vaccines for Covid-19.
COVID-19 Detection Kits Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
The COVID-19 detection kits market size is expected to see exponential growth by 2027 primarily driven by the proliferating demand for COVID-19 testing worldwide. In addition, government mandates requiring COVID-19 negative reports for various purposes, particularly air travel, are also projected to further drive market demand. After the COVID-19 outbreak, there was a booming need for testing across the globe. Moreover, with the emergence of new variants of the novel coronavirus across different regions has facilitated product development to target newly identified viral mutations. Latin America COVID-19 detection kits market valuation reached USD 430 million in 2020 and is speculated to gain a robust footing in the business over 2021-2027. Escalating COVID-19 incidences in Brazil and Mexico are anticipated to drive market demand in the region over the projected timeline.
In order to accommodate the mounting demand for COVID-19 testing, industry players and researchers have been focused on making innovative and cost- and time-efficient detection kits for the COVID-19 infection. As a result, growing emphasis on product development is considerably fostering business outlook.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.